Literature DB >> 24290866

Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.

Amira A M Adly1, Eman A Ismail2, Nevine G Andrawes1, Marwa A El-Saadany1.   

Abstract

OBJECTIVE: Triggering receptor expressed on myeloid cells-1 (TREM-1) is an important receptor involved in the innate inflammatory response and sepsis. We assessed soluble TREM-1 (sTREM-1) in 112 septic neonates (63 culture-positive and 49 culture-negative) and 40 healthy controls as a potential early diagnostic and prognostic marker for neonatal sepsis (NS).
METHODS: Studied neonates were evaluated for early- or late-onset sepsis using clinical and laboratory indicators upon admission. sTREM-1 was measured on initial sepsis evaluation and at 48h after antibiotic therapy. For ethical reasons, cord blood samples were collected from control neonates and only samples from neonates that proved to be healthy by clinical examination and laboratory analysis were further analyzed for sTREM-1.
RESULTS: Baseline sTREM-1 levels were significantly elevated in culture-proven (1461.1±523pg/mL) and culture-negative sepsis (1194±485pg/mL) compared to controls (162.2±61pg/mL) with no significant difference between both septic groups. Culture-positive or negative septic preterm neonates had significantly higher sTREM-1 compared to full term neonates. sTREM-1 was significantly higher in neonates with early sepsis than late sepsis and was associated with high mortality. sTREM-1 was significantly decreased 48h after antibiotic therapy compared to baseline or levels in neonates with persistently positive cultures. sTREM-1 was positively correlated to white blood cells (WBCs), absolute neutrophil count, immature/total neutrophil (I/T) ratio, C-reactive protein (hs-CRP) and sepsis score while negatively correlated to gestational age and weight. hs-CRP and sepsis score were independently related to sTREM-1 in multiregression analysis. sTREM-1 cutoff value of 310pg/mL could be diagnostic for NS with 100% sensitivity and specificity (AUC, 1.0 and 95% confidence interval [CI], 0.696-1.015) while the cutoff value 1100pg/mL was predictive of survival with 100% sensitivity and 97% specificity (AUC, 0.978 and 95% CI, 0.853-1.13). However, hs-CRP cutoff 13.5mg/L could be diagnostic for NS with a sensitivity of 76% and specificity of 72% (AUC, 0.762 and 95% CI, 0.612-0.925) and levels were not related to survival as no significant difference was found between dead and alive septic neonates.
CONCLUSIONS: Elevated sTREM-1 could be considered an early marker for NS that reflects sepsis severity and poor prognosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neonatal sepsis; Outcome; Therapy; hs-CRP; sTREM-1

Mesh:

Substances:

Year:  2013        PMID: 24290866     DOI: 10.1016/j.cyto.2013.11.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  28 in total

Review 1.  Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases.

Authors:  Changlin Cao; Jingxian Gu; Jingyao Zhang
Journal:  Front Med       Date:  2017-04-19       Impact factor: 4.592

2.  TREM-1 signaling promotes host defense during the early stage of infection with highly pathogenic Streptococcus suis.

Authors:  Chao Yang; Bo Chen; Jianqing Zhao; Lan Lin; Li Han; Shan Pan; Lei Fu; Meilin Jin; Huanchun Chen; Anding Zhang
Journal:  Infect Immun       Date:  2015-06-08       Impact factor: 3.441

3.  Soluble Triggering Receptors Expressed on Myeloid Cells-1 as a Neonatal Ventilator-Associated Pneumonia Biomarker.

Authors:  Zu-Qin Yang; Jing-Yun Mai; Min-Li Zhu; Xiu-Man Xiao; Xiao-Xiao He; Shang-Qin Chen; Zhen-Lang Lin; Xing Feng
Journal:  Int J Gen Med       Date:  2021-08-14

4.  Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis.

Authors:  Ming Ying Gan; Wen Li Lee; Bei Jun Yap; Shu Ting Tammie Seethor; Rachel G Greenberg; Jen Heng Pek; Bobby Tan; Christoph Paul Vincent Hornik; Jan Hau Lee; Shu-Ling Chong
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

Review 5.  Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis.

Authors:  Ioannis Bellos; Georgia Fitrou; Georgios Daskalakis; Nikolaos Thomakos; Nikolaos Papantoniou; Vasilios Pergialiotis
Journal:  Inflamm Res       Date:  2018-04-11       Impact factor: 4.575

Review 6.  Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives.

Authors:  Iliana Bersani; Cinzia Auriti; Maria Paola Ronchetti; Giusi Prencipe; Diego Gazzolo; Andrea Dotta
Journal:  Biomed Res Int       Date:  2015-01-18       Impact factor: 3.411

7.  C-reactive protein for diagnosing late-onset infection in newborn infants.

Authors:  Jennifer Valeska Elli Brown; Nicholas Meader; Jemma Cleminson; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14

Review 8.  Biomarkers for Sepsis: What Is and What Might Be?

Authors:  Bethany M Biron; Alfred Ayala; Joanne L Lomas-Neira
Journal:  Biomark Insights       Date:  2015-09-15

9.  Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study.

Authors:  Tania Siahanidou; Alexandra Margeli; Chrysanthi Tsirogianni; Stavroula Charoni; Maria Giannaki; Eustathios Vavourakis; Athina Charisiadou; Ioannis Papassotiriou
Journal:  Mediators Inflamm       Date:  2014-05-05       Impact factor: 4.711

Review 10.  Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review.

Authors:  Giuseppe Pontrelli; Franco De Crescenzo; Roberto Buzzetti; Francesca Calò Carducci; Alessandro Jenkner; Donato Amodio; Maia De Luca; Sara Chiurchiù; Elin Haf Davies; Alessandra Simonetti; Elena Ferretti; Martina Della Corte; Luca Gramatica; Susanna Livadiotti; Paolo Rossi
Journal:  Ital J Pediatr       Date:  2016-04-27       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.